MPW

Medical Properties Trust Inc

Add to Watchlist

Advanced Chart

5.070

+0.03(0.595%)1D

Line

Candle

YTD

High

5.100

Open

5.020

VWAP

5.05

Vol

8.85M

Mkt Cap

2.80B

Low

4.970

Amount

44.68M

EV/EBITDA(TTM)

33.75

Total Shares

600.10M

11.46B

EV/OCF(TTM)

66.82

P/S(TTM)

2.81

Medical Properties Trust, Inc. is a self-advised real estate investment trust (REIT). The Company conducts all of its operations through its subsidiary, MPT Operating Partnership, L.P. It acquires and develops healthcare facilities and leases the facilities to healthcare operating companies under long-term net leases. It also makes mortgage loans to healthcare operators collateralized by their real estate assets. It selectively makes loans to certain of its operators through its taxable REIT subsidiaries (TRS). It has healthcare investments in the United States, Europe and South America. The Company owns hospital real estate with approximately 396 facilities and approximately 39,000 licensed beds in nine countries and across three continents. Its financing model facilitates acquisitions and recapitalizations and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q2

FY2025Q3

FY2025Q4

232.90M

-12.63%

237.76M

+5.29%

244.48M

+5.45%

Estimates Revision

The market is revising No Change the revenue expectations for Medical Properties Trust, Inc. (MPW) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 25.81%.

Revenue Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Up

+25.81%

In Past 3 Month

2 Analyst Rating

8.48% Upside

Wall Street analysts forecast MPW stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MPW is 5.50 USD with a low forecast of 5.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

0 Hold

1 Sell

Hold

8.48% Upside

Current: 5.070

Low

5.00

Averages

5.50

High

6.00

8.48% Upside

Current: 5.070

Low

5.00

Averages

5.50

High

6.00

RBC Capital

Sector Perform

downgrade

2025-06-30

Reason

RBC Capital

Price Target

2025-06-30

downgrade

Sector Perform

Reason

RBC Capital lowered the firm's price target on Medical Properties Trust to $4.50 from $5 and keeps a Sector Perform rating on the shares. The stock will likely remain volatile going forward given the uncertainty regarding a few ongoing tenant situations, the ability to monetize non-revenue generating assets, and the elevated leverage metrics, the analyst tells investors in a research note. RBC adds that it is lowering its estimates to mainly reflect the recent JV debt refinancing and higher operating expense leakage.

Exane BNP Paribas

Nate Crossett

Hold

Buy

Upgrades

$5 → $9

2025-03-12

Reason

Exane BNP Paribas

Nate Crossett

Price Target

$5 → $9

2025-03-12

Upgrades

Hold

Buy

Reason

Exane BNP Paribas analyst Nate Crossett upgraded Medical Properties Trust to Outperform from Neutral with a price target of $9, up from $5. The stock is up sharply year-to-date on developments including new tenant payments following bankruptcy of tenant Steward, and the firm contends that shares can continue to re-rate higher as new tenant payments continue to ramp, the analyst tells investors in a research note. The firm believes that earnings of Medical Properties Trust should go higher over time.

Wells Fargo

Connor Siversky

Sell

Maintains

$4 → $5

2025-03-10

Reason

Wells Fargo

Connor Siversky

Price Target

$4 → $5

2025-03-10

Maintains

Sell

Reason

Wells Fargo raised the firm's price target on Medical Properties Trust to $5 from $4 and keeps an Underweight rating on the shares. The firm notes Q1 was a strong start for Medical Properties Trust as it completed a private offering of senior secured notes that addressed all of its maturities until October 2026.

RBC Capital

Michael Carroll

Hold

Maintains

$4 → $5

2025-03-10

Reason

RBC Capital

Michael Carroll

Price Target

$4 → $5

2025-03-10

Maintains

Hold

Reason

RBC Capital raised the firm's price target on Medical Properties Trust to $5 from $4 and keeps a Sector Perform rating on the shares. The company is making progress in stabilizing its troubled tenants and satisfying the upcoming capital commitments, though there is still a wide range of potential outcomes highlighted by the new tenants' ability to turn around the former Steward hospitals and the management's ability to monetize non-revenue generating assets, the analyst tells investors in a research note.

Truist Securities

Michael Lewis

Hold

Maintains

$6 → $4

2024-12-19

Reason

Truist Securities

Michael Lewis

Price Target

$6 → $4

2024-12-19

Maintains

Hold

Reason

Mizuho

Vikram Malhotra

Hold

Maintains

$6 → $5

2024-12-05

Reason

Mizuho

Vikram Malhotra

Price Target

$6 → $5

2024-12-05

Maintains

Hold

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for Medical Properties Trust Inc (MPW.N) is 69.17, compared to its 5-year average forward P/E of 12.57. For a more detailed relative valuation and DCF analysis to assess Medical Properties Trust Inc 's fair value, click here.

Forward PE
Forward EV/EBITDA
Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

12.57

Current PE

69.17

Overvalued PE

37.97

Undervalued PE

-12.83

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair

5Y Average EV/EBITDA

14.33

Current EV/EBITDA

14.41

Overvalued EV/EBITDA

15.70

Undervalued EV/EBITDA

12.97

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Undervalued

5Y Average PS

5.12

Current PS

2.80

Overvalued PS

7.40

Undervalued PS

2.84

Financials

Annual

Quarterly

FY2025Q1

YoY :

-17.51%

223.80M

Total Revenue

FY2025Q1

YoY :

-30.01%

110.28M

Operating Profit

FY2025Q1

YoY :

-86.52%

-118.02M

Net Income after Tax

FY2025Q1

YoY :

-86.30%

-0.20

EPS - Diluted

FY2025Q1

YoY :

-246.17%

-64.98M

Free Cash Flow

FY2025Q1

YoY :

-1.38%

96.86

Gross Profit Margin - %

FY2025Q1

YoY :

-127.32%

-5.21

FCF Margin - %

FY2025Q1

YoY :

-83.66%

-52.73

Net Margin - %

FY2025Q1

N/A

ROIC

Trading Trends

Insider
Hedge Fund
Congress Trading

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

150.8K

USD

0-12

Months

54.3K

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

42.6K

USD

Months

0-12

0.0

USD

Months

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

0-3

Months

0.0

Volume

3-6

Months

0.0

Volume

6-9

Months

784.6K

Volume

0-12

Months

4.8M

Volume

Bought

0-3

0.0

Volume

Months

3-6

5.7M

Volume

Months

6-9

3.3M

Volume

Months

0-12

0.0

Volume

Months

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

150.8K

USD

0-12

Months

54.3K

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

42.6K

USD

Months

0-12

0.0

USD

Months

MPW News & Events

Events Timeline

2025-10-30 (ET)

2025-10-30

09:06:17

Medical Properties Trust Announces Q3 EPS of 13 Cents, Below Consensus Estimate of 2 Cents

2025-09-29 (ET)

2025-09-29

08:10:11

Medical Properties Trust Offers Update on Portfolio

2025-08-28 (ET)

2025-08-28

17:02:54

Medical Properties Trust Secures New Lease Agreement for Six Facilities in California

News

8.0

10-30SeekingAlpha

Medical Properties Trust Aims for $1B Annual Cash Rent by 2026 with New $150M Share Buyback Plan Following Tenant Performance Improvements

9.5

10-30SeekingAlpha

Earnings Overview: Medical Properties Trust falls short of Q3 revenue expectations; FFO meets projections

9.5

10-30SeekingAlpha

Medical Properties Trust Reports Strong Q3 Earnings, Revenue Falls Short Despite Improved Cash Rent

People Also Watch

MTX

Minerals Technologies Inc

ICF International Inc

Arrowhead Pharmaceuticals Inc

FAQ

What is Medical Properties Trust Inc (MPW) stock price today?

The current price of MPW is 5.07 USD — it has increased 0.6 % in the last trading day.

MPW

Market Estimates

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Trading Trends

MPW News & Events

Events Timeline

News

People Also Watch

FAQ

What is Medical Properties Trust Inc (MPW) stock price today?

What is Medical Properties Trust Inc (MPW)'s business?

What is the price predicton of MPW Stock?

What is Medical Properties Trust Inc (MPW)'s revenue for the last quarter?

What is Medical Properties Trust Inc (MPW)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Medical Properties Trust Inc (MPW)'s fundamentals?

How many employees does Medical Properties Trust Inc (MPW). have?

What is Medical Properties Trust Inc (MPW) market cap?